Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
G201-Na
- Development stage
- Unknown
- Lead developer
- Yiling Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
G201-Na is an orally bioavailable, small-molecule gonadotropin-releasing hormone (GnRH) receptor antagonist developed by Shijiazhuang Yiling Pharmaceutical. It functions by competitively binding to the GnRH receptors in the anterior pituitary gland, which prevents endogenous GnRH from stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In oncology, this suppression leads to a rapid decline in serum testosterone levels, providing a medical castration effect suitable for treating metastatic prostate cancer. In reproductive medicine, G201-Na is being investigated for use in women undergoing assisted reproductive technology (ART) to prevent premature LH surges during controlled ovarian hyperstimulation (COH), potentially offering a more convenient oral alternative to traditional injectable GnRH antagonists.
- Other names
- G201 sodiumG-201 sodiumG 201 sodium
02
Targets
GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on G201-Na.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on G201-Na.